Efficiency/Biotech & Pharma

Deploy a Chief Operating Officer for your biotech or pharma company.

Bypass bloated consulting firms. Secure a US-based, Ivy League-educated COO to navigate crossover or series c fundraise — entirely remotely, deployed in 48 hours.

48 hr
Avg. Deployment
100%
US-Based · Ivy League
14 day
No-Cause Cancellation
The Mandate

What Biotech & Pharma CEOs hire COOs to solve.

  • 01Capital efficiency between trial milestones
  • 02Clinical, regulatory and commercial coordination
  • 03BD, licensing and pharma-partner negotiations
  • 04GxP, quality and supply chain readiness
Common Engagements

Where this COO plugs in across Biotech & Pharma.

Crossover or Series C fundraise

Scaling from 50 to 250 employees in 18 months

BD and licensing program

Post-merger integration of operations and systems

Commercial launch preparation

Margin recovery program in physical-product businesses

Quality and compliance overhaul

Implementing a real operating cadence for the first time

Ready to DeployYour operator can be on the inside by Thursday.Choose a Tier
Deliverables

What lands in week one.

  • Operating system playbook (meetings, OKRs, dashboards)
  • Department-by-department SOP library
  • Vendor scorecard and supply chain risk map
  • Cost-to-serve analysis with reduction roadmap
KPIs Owned

The scoreboard they answer to.

  • ·Gross margin expansion (bps)
  • ·On-time, in-full delivery rate
  • ·Quarterly OKR completion rate
  • ·Operating leverage (revenue per FTE)

A Crimson Bench COO turns founder-dependent operations into a repeatable company operating system: clear processes, visible metrics, stronger managers, and execution rhythm across every department.

Still Evaluating?

Start with a $1,500 Executive Diagnostic — 2 hours, 3-page roadmap, refundable.

Live Bench